Healthcare Global Enterprises Ltd

AI
Health.Global Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents
AI

Healthcare Global Enterprises Ltd

₹ 558 1.27%
22 Oct 3:50 p.m.
hcgoncology.com BSE: 539787 NSE: HCG
About

Healthcare Global Enterprises Ltd is engaged in setting up and managing hospitals and medical diagnostic services including scientific testing and consultancy services in the pharmaceutical and medical sector.[1]

Key Points

Service Offering
The Company is a provider of specialty healthcare focused on cancer and fertility. Under the “HCG” brand, it operates the largest cancer care network in India in terms of the total number of private cancer treatment centers licensed by the AERB. It also provides fertility treatment under our “Milann” brand. [1]

Website BSE NSE
  • Market Cap ₹ 8,334 Cr.
  • Current Price ₹ 558
  • High / Low ₹ 800 / 513
  • Stock P/E 173
  • Book Value ₹ 89.2
  • Dividend Yield 0.00 %
  • ROCE 8.30 %
  • ROE 2.54 %
  • Face Value ₹ 10.0
Edit ratios

Pros

Cons

  • Stock is trading at 6.23 times its book value
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has low interest coverage ratio.
  • Company has a low return on equity of 4.24% over last 3 years.
  • Promoter holding has decreased over last 3 years: -7.09%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Healthcare Services Hospital

Part of BSE Healthcare BSE 1000 Nifty Total Market BSE Hospitals Nifty Smallcap 500

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
461 487 470 495 526 554 559 585 613 647 633 652 695
386 402 391 403 435 451 470 480 505 524 524 527 573
Operating Profit 74 85 79 92 91 102 88 106 108 123 110 125 122
OPM % 16% 17% 17% 19% 17% 18% 16% 18% 18% 19% 17% 19% 18%
3 3 6 9 9 11 6 10 8 3 -10 -18 13
Interest 26 27 29 27 34 36 41 44 45 44 45 43 40
Depreciation 41 43 44 46 47 50 57 58 58 63 61 63 70
Profit before tax 11 18 11 28 19 28 -3 14 12 20 -6 1 25
Tax % 65% 40% 69% 17% 28% 25% -335% 50% 50% -4% 30% -223% 34%
4 11 3 23 14 21 8 7 6 21 -8 4 16
EPS in Rs 0.52 0.92 0.39 1.44 0.82 1.22 0.47 0.50 0.32 1.09 -0.63 0.15 0.92
Raw PDF
Upcoming result date: 5 November 2026

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
519 584 700 829 976 1,092 1,009 1,395 1,691 1,908 2,218 2,538 2,627
443 499 595 713 864 936 887 1,161 1,394 1,581 1,835 2,080 2,147
Operating Profit 76 85 105 116 112 157 122 234 297 327 384 459 480
OPM % 15% 15% 15% 14% 11% 14% 12% 17% 18% 17% 17% 18% 18%
0 -2 10 25 10 10 -72 110 15 24 39 -11 -13
Interest 34 38 23 42 70 138 119 98 104 109 155 177 171
Depreciation 39 44 57 71 85 148 159 158 163 174 211 244 257
Profit before tax 3 0 35 27 -33 -119 -229 88 45 68 57 27 40
Tax % -56% -730% 34% 38% -7% 5% -3% 56% 61% 39% 14% 15%
5 2 23 17 -31 -125 -221 39 18 41 49 23 33
EPS in Rs 0.11 -0.16 2.44 2.23 -2.66 -11.36 -14.58 3.65 1.99 3.27 3.01 0.92 1.53
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: 16%
5 Years: 20%
3 Years: 14%
TTM: 14%
Compounded Profit Growth
10 Years: 39%
5 Years: 18%
3 Years: -1%
TTM: 30%
Stock Price CAGR
10 Years: 9%
5 Years: 19%
3 Years: 15%
1 Year: -23%
Return on Equity
10 Years: -1%
5 Years: 4%
3 Years: 4%
Last Year: 3%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 70 85 86 87 88 89 125 139 139 139 139 149
Reserves 210 341 347 428 389 293 572 731 721 686 783 1,183
349 324 420 464 658 1,347 977 915 901 1,274 1,837 1,735
147 294 372 461 515 518 357 433 549 601 780 853
Total Liabilities 776 1,043 1,225 1,440 1,650 2,246 2,031 2,218 2,311 2,701 3,540 3,920
528 583 685 828 970 1,646 1,382 1,547 1,553 1,758 2,442 2,462
CWIP 42 121 148 174 153 46 30 22 18 83 25 19
Investments 0 64 11 53 49 34 26 9 10 10 11 14
205 275 381 385 478 520 593 641 730 850 1,062 1,426
Total Assets 776 1,043 1,225 1,440 1,650 2,246 2,031 2,218 2,311 2,701 3,540 3,920

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
60 73 91 98 98 130 121 220 252 285 317 347
-79 -204 -210 -283 -238 -101 -171 125 -133 -226 -488 -177
22 216 89 161 84 -58 112 -155 -140 -64 -42 241
Net Cash Flow 2 85 -29 -24 -56 -30 62 190 -22 -5 -213 410
Free Cash Flow -20 -137 -101 -158 -90 23 85 150 126 101 110 59
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit 87% 99% 93% 88% 121% 100% 68% 104% 92% 101% 91% 83%

Ratios

Consolidated / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 45 43 54 57 59 62 67 57 65 56 66 60
Inventory Days 36 32 40 46 45 35 32 31 33 33 33 32
Days Payable 208 264 272 274 303 234 221 199 214 216 210 185
Cash Conversion Cycle -127 -188 -178 -171 -200 -136 -121 -112 -116 -127 -111 -93
Working Capital Days -65 -96 -112 -74 -110 -102 -26 -43 -40 -70 -91 -61
ROCE % 7% 6% 7% 6% 3% 1% -1% 5% 8% 9% 9% 8%

Insights

In beta
Mar 2010 Mar 2015 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Average Occupancy Rate (AOR)
%

Log in to view insights

Please log in to see hidden values.

Login
Number of LINACs
LINACs
Capacity Beds (Installed)
Beds
Number of Hospitals
Hospitals
Operating Theatres
OTs
Operational Beds
Beds
ARPP (Average Revenue Per Patient, excl Fertility)
INR per patient
IP Patient Volumes (excl Fertility)
IP patients

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

1 Recently
Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
71.29% 71.28% 71.26% 71.23% 71.22% 71.22% 62.46% 63.78% 63.77% 64.21% 64.21% 64.21%
6.37% 6.74% 3.95% 4.30% 2.77% 2.44% 2.16% 3.59% 3.22% 2.76% 2.73% 2.70%
8.46% 8.52% 10.89% 11.64% 12.94% 12.48% 13.22% 18.36% 18.30% 18.91% 19.20% 20.78%
13.89% 13.45% 13.90% 12.84% 13.07% 13.86% 22.17% 14.28% 14.71% 14.15% 13.86% 12.32%
No. of Shareholders 27,28927,19526,52929,67032,82045,39447,02846,97045,36647,64948,90544,774

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls